TRDA- Entrada Therapeutics, Inc.

Name: Entrada Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 7 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	5am Ventures V, L.P.	2.96M	$21.01M	-
10%	Parmar Kush	2.96M	$21.01M	-
CEO	Doshi Dipal	526.0K	$3.73M	-
10%	Baker Bros. Advisors LP	381.3K	$2.70M	-
Pres	Sethuraman Natarajan	216.3K	$1.53M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 13, 2024	Doshi Dipal62	CEO	Sell	1,000	$16.17	$16,173.60	-0.3%	-9.7%	-53.9%
May 20, 2024	Sethuraman Natarajan83	Chief Scientific Officer	Sell	18,980	$15.16	$287,694.89	-3.1%	+7.8%	-46.2%
May 17, 2024	Doshi Dipal62	CEO	Sell	3,000	$15.04	$45,129.12	-0.4%	+8.5%	-46.0%
May 14, 2024	Kim Peter S48	Director	Buy	25,000	$14.59	$364,672.50	+37.1%	+0.1%	-43.8%
May 9, 2024	Kim Peter S48	Director	Buy	4,476	$14.14	$63,305.58	+3.5%	-3.8%	-41.6%
Apr 8, 2024	Kim Peter S48	Director	Buy	2,600	$13.57	$35,289.80	+4.3%	+12.6%	-43.9%
Mar 28, 2024	Kim Peter S48	Director	Buy	1,512	$13.75	$20,793.93	+2.6%	-0.5%	-32.5%
Mar 26, 2024	Kim Peter S48	Director	Buy	9,048	$13.58	$122,881.82	+5.7%	+3.5%	-28.1%
Mar 21, 2024	Kim Peter S48	Director	Buy	2,732	$12.81	$34,995.55	+1.9%	+6.6%	-22.5%
Mar 6, 2024	Wentworth Kory James61	Chief Financial Officer	Sell	4,086	$12.31	$50,285.18	-5.2%	+23.5%	-15.9%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC